返回ChemicalBook首页>CAS数据库列表>1811510-56-1

1811510-56-1

中文名称 化合物PF6260933
英文名称 PF-6260933
CAS 1811510-56-1
分子式 C16H13ClN4
分子量 296.75
MOL 文件 1811510-56-1.mol
更新日期 2023/03/20 15:41:27
1811510-56-1 结构式 1811510-56-1 结构式

基本信息

中文别名
化合物PF6260933
英文别名
PF06260933
PF-6260933
[3,3'-Bipyridine]-6,6'-diamine, 5-(4-chlorophenyl)-
PF 06260933
PF06260933
PF6260933
PF 6260933
PF-6260933
所属类别
生物化工:激动剂抑制剂

物理化学性质

沸点483.8±40.0 °C(Predicted)
密度1.330±0.06 g/cm3(Predicted)
储存条件-20°C储存
溶解度DMF: 1 mg/ml; DMSO: 1 mg/ml; Ethanol: insol; PBS (pH 7.2): insol
酸度系数(pKa)5.04±0.13(Predicted)
形态固体

安全数据

危险性符号(GHS)
GHS07
警示词警告
危险性描述H302-H315-H319-H335
海关编码2933998090

常见问题列表

生物活性
PF-6260933 (PF-06260933)是MAP4K4抑制剂,IC50为3.7 nM,具有良好的激酶组选择性。
靶点
TargetValue
MAP4K4
()
3.7 nM
体外研究

PF-06260933 treatment of human aortic endothelial cell (EC) robustly prevents TNF-α-mediated endothelial permeability in vitro , similar to MAP4K4 knockdown.

体内研究

In the mice model, PF-06260933 treatment does not alter plasma lipid content, although reductions in glucose levels are observed, which is consistent with whole-body-inducible Map4k4 knockout animals. PF-06260933 administration ameliorates further plaque development and/or promotes plaque regression in this animal model (46.0% versus 25.5%), and a reduction in plasma glucose as well as lipid content is also observed.

"1811510-56-1" 相关产品信息
168828-58-8 1301214-47-0 1435467-37-0 1166393-85-6 1817626-54-2 1332708-14-1 875051-72-2 1197160-78-3 939791-38-5 2102501-84-6 1035638-91-5 72882-78-1 947303-87-9 198474-05-4 2140301-96-6 898044-15-0 1220699-06-8 1467057-23-3